Ranolazine: novel add‐on treatment for stable angina
Authors
Abstract
Ranolazine is a new anti‐anginal drug with a novel mode of action. In our New products review, Steve Chaplin discusses the clinical data relating to its efficacy and safety, and Dr Connolly describes its place in angina management. Copyright © 2009 Wiley Interface Ltd.
Digital Object Identifier (DOI)
10.1002/psb.539 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
